Wednesday, Jun 18

Category: TVAM

New TVAM Study Published in Acta Phlebologica

Michael Arata MD of Synergy Health Concepts published the results of a new study into the safety and effectiveness of the TVAM procedure in patients with autonomic dysfunction. The study was published in the April 2014 edition of Acta Phlebologica: A Journal on Phlebology. Transvascular autonomic modulation (TVAM) is a

A New Approach to Treating MS Patients

As MS patients are all too well aware, multiple sclerosis can cause a wide range of symptoms, from weakness and numbness to visual changes. But most MS patients don’t realize that they are very likely to have another condition known as autonomic dysfunction, or dysautonomia, and that it is dysautonomia

New Study Finds Relationship Between Fibromylagia and Autonomic Dysfunction; Suggests New Treatment Options

A recent study published in the Journal of Clinical Rheumatology explores the connection between fibromyalgia and sympathetic nervous system dysfunction. This meta-study found that 65% of case-control studies found in the PubMed and EMBASE databases described “sympathetic nervous system predominance” as the “common clustering underlying pathogenesis”1, meaning that the onset

Treating Fibromyalgia Patients in a Whole New Way

Fibromyalgia is a difficult syndrome to diagnose and to treat. Worse yet for fibro patients, a large portion of the medical community still does not recognize fibromyalgia as a real or serious condition. What treatments do exist are inconsistent in their effectiveness and largely treat very specific symptoms like pain

Studies Investigate Relationship Between New Treatment and Reduction in Dysautonomia Symptoms in MS Patients

Synergy Health has published a new study, the first in a series, investigating the relationship between treatment for CCSVI (and its successor treatment, TVAM therapy) and the improvement of the symptoms of dysautonomia among M.S. Patients and other groups suffering from autonomic dysfunction. Read our latest study here: While

A Promising New Treatment for Dysautonomia Patients

Most patients diagnosed with isolated or “pure” dysautonomia – autonomic dysfunction with no underlying neurological condition – generally first seek medical treatment for cardiovascular issues, such as POTS (where the heart rate fluctuates based on body position) or syncope (the tendency to pass out frequently). As a result, dysautonomia is

The Current Status of CCSVI Treatment

Since the condition known as chronic cerebrospinal venous insufficiency (CCSVI) was first described by Dr. Paolo Zamboni in 2008, the relationship between this condition and MS has been investigated and rigorously debated. Yet while Zamboni’s original study saw an over 90% correlation between MS and CCSVI, later studies have cast